Page 643 - Concise Pathology for Exam Preparation ( PDFDrive )
P. 643

628  Index

         K                             Lipoxin, 40                  Molecular techniques in pathology
         Kallikrein, 45                Liver function tests, 421–422   (Continued)
         Kartagener syndrome, 364      Lobar pneumonia, 163–165      fluorescence in situ hybridization
         Karyotype, 338                Low density lipoprotein, 196      (FISH), 200
         Keloid, 66                    Lyme disease, 619             hybridization, 198
         Killer T cells, 94            Lymphangitis, 236–237         in situ hybridization, 199
         Kimmelsteil—Wilson disease, 479  Lymphedema, 236–237        northern hybridization, 199
         Klatskin tumours, 448         Lymphocytosis, 318            polymerase chain reaction (PCR),
         Kinin and clotting system, 7  Lyon’s hypothesis, 194            199–200
         KLF6, 140                     Lysosomal storage diseases, 202–204  Southern blotting, 198
         Klinefelter’s syndrome, 194–195  Fabry’s disease, 204       Western blotting, 199
         Koilocyte, 384                 Gaucher’s disease, 203      Monocytosis, 318
         Korsakoff ’s syndrome, 212     Krabbes disease, 204        Monosodium urate, 597
         KRAS, 136                      metachromatic leukodystrophy,    Morphologic patterns of acute
         Krukenberg tumor, 518             203–204                     inflammation, 46–47
         Kupffer cells, 50, 116, 183, 420, 437,   Niemann’Pick disease, 203  Mosaicism, 192
             439                        Tay’Sachs disease, 203      Mucinous
                                                                     Cystadenoma, 515
                                                                     Cystadenocarcinoma, 513
         L                             M                            Mucinous degeneration, 24
         Labile/continuously dividing cells, 53  MacCallum plaque, 270  Mucoepidermoid carcinoma, 389
         Laboratory diagnosis of cancer,    Macroglossia, 117, 485  Multiple myeloma, 343–344
             146–149                   Major basic protein, 49      Mumps, 169–170
         Lactiferous sinus, 524        Malabsorption syndrome, 404–405  Mutation, 190
         Lambert’Eaton myasthenic      Malaria, 181                 Myasthenia gravis, 601
             syndrome, 601             Mallory hyaline/Mallory–Denk bodies,   Mycobacterium
         Lamellar bone, 569               437                        Bovis, 406
         Langerhans cell, 603          Marjolin’s ulcer, 608         Leprae, 229
         Lardaceous spleen, 116        Marrow expansion, 311         Tuberculosis, 51, 157
         Large cell carcinoma of lung, 382  Mast cells, 49           Mycolic acid, 157, 161
         Large white kidney, 486       Measles, 169                 Mycosis fungoides, 340
         Lead toxicity, 214            Medullary carcinoma          Myelodysplastic syndrome, 330–331
         Leather bottle stomach, 402    of breast, 527              Myeloperoxidase deficiency, 38
         Leiomyoma, 510                 of thyroid, 115             Myeloproliferative diseases, 319, 327
         Leishmaniasis, 183–184        Megaloblastic anemia, 300–302  Myocardial infarction, 258–260
         Lepra cells, 162              Meigs syndrome, 518          Myocarditis, 277–278
         Lepromin reaction, 105        Melanin, 25–26               Myxedema, 538
         Leprosy or Hansen’s disease, 161  Melanocytic disorders of skin, 610–612
         Leptomeningitis, 615          Melanosis coli, 27
         Leukemias, 321–323            Membranous glomerulonephritis,    N
           acute leukemias, 321, 323      469–470                   Natural killer cell, 93
           chronic leukemias, 322      Mendelian disorders, 196–197  Necrosis, 16
           chronic lymphocytic, 341–342  Menetrier disease, 400      caseous, 14
           chronic myelocytic (myeloid),    Meningioma, 400          coagulative, 12–13
              327–329                  Meningovascular, 168          fibrinoid 16
           leukemic infiltration of tissues, 324  Meningitis, 615–617  liquefactive, 13
         Leukemoid reactions, 318–319  Metabolic and endocrine diseases of   Neisseria gonorrhoeae, 156
           lymphoid leukemoid reactions, 319  bone, 589             Neonatal respiratory distress
           myeloid leukemoid reactions, 318  osteomalacia and rickets, 589  syndrome/hyaline membrane
         Leukocyte adhesion molecules, 35  osteporosis, 589            disease, 206–207
           immunoglobulin superfamily, 35  renal osteodystrophy, 590–591  Neoplasia, 123
           integrins, 35                scurvy, 589                 Neoplastic polyps, 412
           mucin-like glycoproteins, 35  Metaplasia, 7              Nephrotic syndrome, 468–474
           selectins, 35               Metastasis, 141              Nephrotoxic ATI, 479
         Leukocytosis, 46              MicroRNAS, 135               Neuroblastoma, 209–210
         Leukoplakia, 385              Microbial carcinogenesis, 144–145  Neurofibromatosis, 26
         Leukotrienes, 98              Microcytic hypochromic anemia, 295  Neurons, 613
         Leydig cell tumors, 494       Microscopic polyangiitis, 233–234  Neuropeptides, 42
         Lichen planus, 605–606        Miliary tuberculosis, 159    Neurosyphilis, 617
           Colloid or Civatte bodies, 606  Milroy disease, 237      Neutrophilia, 317
           Interface dermatitis, 606   Minimal change disease, 470  Nevus cells, 611
           Wickham’s striae, 605       Missense mutations, 190      Nicotine, 212
         Lichen simplex chronicus, 606  Mitochondrial DNA (mtDNA)   Nitric oxide, 562
         Li-Fraumeni syndrome, 131, 139, 528,   disorders, 198      Nitroblue tetrazolium test, 565
             576                       Mitral stenosis, 73, 270     Nocturia, 459
         Linea nigra, 26               Mitsuda reaction, 105        Nodular hyperplasia of prostate, 497–499
         Lipiduria, 459, 463, 468–469, 475  Mixed cellularity disease (MCD),    Nonalcoholic steatohepatitis
         Lipoarabinomannan, 157           332, 334                     (NASH), 434
         Lipofuscin, 26                Molecular techniques in pathology,   Nonenzymatic glycosylation, 248
         Lipopolysaccharide endotoxin     198–199                   Non-Hodgkin’s lymphoma (NHL), 335
             (LPS), 107                 dot blot hybridization, 199  Non-neoplastic polyps, 411–412



                                  mebooksfree.com
   638   639   640   641   642   643   644   645